Please assess the completion status of the following clinical trial:

Trial Title: Temporary Clamping of Drains Combined With Tranexamic Acid Reduce Blood Loss After TKA: A Prospective RCT

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* The patients younger than 85 years with knee osteoarthritis~Exclusion Criteria:~* The patient diagnosed secondary osteoarthritis (eg, rheumatoid arthritis, posttraumatic arthritis, gouty arthritis, postseptic arthritis)~* High-risk medical comorbid patient~* The patient who was planed for simultaneous bilateral TKAs~* The patient who had history of thromboembolic disease or bleeding disorder~* The patient who was receiving anticoagulant drug treatment~* The patient who had allergy to tranexamic acid

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Group A (Type: EXPERIMENTAL): No clamp and placebo
- Group B (Type: EXPERIMENTAL): Tranexamic acid
- Group C (Type: EXPERIMENTAL): Drain clamping
- Group D (Type: EXPERIMENTAL): Drain clamping and tranexamic acid

Based on this trial design, predict the completion outcome and termination type (if applicable).